Profile
Noreen Roth Henig is currently an Independent Director at Lazard Healthcare Acquisition Corp.
I.
Former positions include Independent Director at Avidity Biosciences, Inc. (2019–2026), Independent Director at Lazard Growth Acquisition Corp.
I (2021–2023), Chief Medical Officer at Kezar Life Sciences, Inc. (2020–2023), Chief Medical Officer at Breath Therapeutics GmbH (2018–2020), Chief Development Officer at ProQR Therapeutics NV (2014–2017), Senior Director-Global Respiratory at Gilead Sciences, Inc. (2011–2014), and Director-Adult Cystic Fibrosis Care Centers at Cystic Fibrosis Foundation (1999–2008).
Education includes an undergraduate degree from Yale University (1987) and a doctorate from Albert Einstein College of Medicine, Inc. (1991).
Noreen Henig active positions
| Companies | Position | Start |
|---|---|---|
Lazard Healthcare Acquisition Corp. I
Lazard Healthcare Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Director/Board Member | - |
Former positions of Noreen Henig
| Companies | Position | End |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Director/Board Member | 27/02/2026 |
| KEZAR LIFE SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 06/10/2023 |
| LAZARD GROWTH ACQUISITION CORP. I | Director/Board Member | 01/02/2023 |
Breath Therapeutics GmbH
Breath Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Develops inhalation drug therapies for severe respiratory diseases | Chief Tech/Sci/R&D Officer | 01/03/2020 |
| PROQR THERAPEUTICS N.V. | Corporate Officer/Principal | 01/11/2017 |
Training of Noreen Henig
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Avidity Biosciences, Inc.
Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation Miscellaneous Commercial ServicesCommercial Services Provides healthcare services and programs | Commercial Services |
Albert Einstein College of Medicine, Inc.
Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProQR Therapeutics NV
ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Breath Therapeutics GmbH
Breath Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Develops inhalation drug therapies for severe respiratory diseases | Health Technology |
Lazard Growth Acquisition Corp. I
Lazard Growth Acquisition Corp. I SemiconductorsElectronic Technology Operates as a blank check company | Electronic Technology |
Lazard Healthcare Acquisition Corp. I
Lazard Healthcare Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Stock Market
- Insiders
- Noreen Henig
















